SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B. G. Warner, W. G. H. Abbott, A. G. Rodrigo, Frequency-dependent selection drives HBeAg seroconversion in chronic hepatitis B virus infection, Evolution, Medicine, and Public Health, 2014, 2014, 1, 1

    CrossRef

  2. You have free access to this content2
    Jia-Horng Kao, HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?, Liver International, 2014, 34,
  3. 3
    George K. K. Lau, Interferon for Chinese patients with chronic hepatitis B e antigen-positive diseases—the controversy arises again?, Hepatology International, 2014,

    CrossRef

  4. 4
    Yong-Yuan Zhang, Ke-Qin Hu, Zhongping Duan, New perspective on the natural course of chronic HBV infection, Frontiers of Medicine, 2014, 8, 2, 129

    CrossRef

  5. 5
    Tai-Chung Tseng, Jia-Horng Kao, Ding-Shinn Chen, Peginterferon α in the treatment of chronic hepatitis B, Expert Opinion on Biological Therapy, 2014, 14, 7, 995

    CrossRef

  6. 6
    Phunchai Charatcharoenwitthaya, Teerha Piratvisuth, Baseline and On-treatment Predictors of Chronic Hepatitis B Patients Receiving Pegylated Interferon Therapy in Asia, Current Hepatitis Reports, 2013, 12, 3, 165

    CrossRef

  7. 7
    Chih-Lin Lin, Jia-Horng Kao, Hepatitis B viral factors and treatment responses in chronic hepatitis B, Journal of the Formosan Medical Association, 2013, 112, 6, 302

    CrossRef